THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY

Name: Work Video:
Duration: 3 min 30 s
Roy Fleischmann; In Ho Song; Jeffrey Enejosa; Eduardo Mysler; Louis Bessette; Patrick Durez; A. Östör; Jerzy Świerkot; Yong Song; Mark C. Genovese
{'id': 'https://openalex.org/W3034508941', 'doi': 'https://doi.org/10.1136/annrheumdis-2020-eular.1418', 'title': 'THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY', 'display_name': 'THU0201 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM THE SELECT-COMPARE STUDY', 'publication_year': 2020, 'publication_date': '2020-06-01', 'ids': {'openalex': 'https://openalex.org/W3034508941', 'doi': 'https://doi.org/10.1136/annrheumdis-2020-eular.1418', 'mag': '3034508941'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2020-eular.1418', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5046261111', 'display_name': 'Roy Fleischmann', 'orcid': 'https://orcid.org/0000-0002-6630-1477'}, 'institutions': [{'id': 'https://openalex.org/I4210096290', 'display_name': 'Metroplex Clinical Research Center', 'ror': 'https://ror.org/00y21a678', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210096290']}, {'id': 'https://openalex.org/I867280407', 'display_name': 'The University of Texas Southwestern Medical Center', 'ror': 'https://ror.org/05byvp690', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I867280407']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. Fleischmann', 'raw_affiliation_strings': ['Univ of Texas Southwestern Med Center, Metroplex Clinical Research Center, Dallas, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Univ of Texas Southwestern Med Center, Metroplex Clinical Research Center, Dallas, United States of America', 'institution_ids': ['https://openalex.org/I4210096290', 'https://openalex.org/I867280407']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018417745', 'display_name': 'In Ho Song', 'orcid': 'https://orcid.org/0000-0001-6330-3453'}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'I. H. Song', 'raw_affiliation_strings': ['AbbVie Inc., North Chicago, United States of America'], 'affiliations': [{'raw_affiliation_string': 'AbbVie Inc., North Chicago, United States of America', 'institution_ids': ['https://openalex.org/I2948539688']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074748590', 'display_name': 'Jeffrey Enejosa', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'J. Enejosa', 'raw_affiliation_strings': ['AbbVie Inc., North Chicago, United States of America'], 'affiliations': [{'raw_affiliation_string': 'AbbVie Inc., North Chicago, United States of America', 'institution_ids': ['https://openalex.org/I2948539688']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000779664', 'display_name': 'Eduardo Mysler', 'orcid': 'https://orcid.org/0000-0002-8993-0313'}, 'institutions': [], 'countries': ['AR'], 'is_corresponding': False, 'raw_author_name': 'E. Mysler', 'raw_affiliation_strings': ['Organización Medica de Investigación, Buenos Aires, Argentina'], 'affiliations': [{'raw_affiliation_string': 'Organización Medica de Investigación, Buenos Aires, Argentina', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054685224', 'display_name': 'Louis Bessette', 'orcid': 'https://orcid.org/0000-0002-6834-2731'}, 'institutions': [{'id': 'https://openalex.org/I43406934', 'display_name': 'Université Laval', 'ror': 'https://ror.org/04sjchr03', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I43406934']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'L. Bessette', 'raw_affiliation_strings': ['Laval Univ, Quebec, Canada'], 'affiliations': [{'raw_affiliation_string': 'Laval Univ, Quebec, Canada', 'institution_ids': ['https://openalex.org/I43406934']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083576726', 'display_name': 'Patrick Durez', 'orcid': 'https://orcid.org/0000-0002-7156-2356'}, 'institutions': [{'id': 'https://openalex.org/I1315288073', 'display_name': 'Cliniques Universitaires Saint-Luc', 'ror': 'https://ror.org/03s4khd80', 'country_code': 'BE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1315288073']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'P. Durez', 'raw_affiliation_strings': ['Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, UCL Saint-Luc, Brussels, Belgium'], 'affiliations': [{'raw_affiliation_string': 'Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, UCL Saint-Luc, Brussels, Belgium', 'institution_ids': ['https://openalex.org/I1315288073']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009877697', 'display_name': 'A. Östör', 'orcid': 'https://orcid.org/0000-0002-7929-4827'}, 'institutions': [{'id': 'https://openalex.org/I4210093052', 'display_name': 'Cabrini Hospital', 'ror': 'https://ror.org/00qbkg805', 'country_code': 'AU', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210093052']}, {'id': 'https://openalex.org/I56590836', 'display_name': 'Monash University', 'ror': 'https://ror.org/02bfwt286', 'country_code': 'AU', 'type': 'education', 'lineage': ['https://openalex.org/I56590836']}], 'countries': ['AU'], 'is_corresponding': False, 'raw_author_name': 'A. Ostor', 'raw_affiliation_strings': ['Cabrini Medical Center, Monash University, Malvern, Australia'], 'affiliations': [{'raw_affiliation_string': 'Cabrini Medical Center, Monash University, Malvern, Australia', 'institution_ids': ['https://openalex.org/I4210093052', 'https://openalex.org/I56590836']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072847615', 'display_name': 'Jerzy Świerkot', 'orcid': 'https://orcid.org/0000-0003-3606-173X'}, 'institutions': [{'id': 'https://openalex.org/I385303915', 'display_name': 'Wroclaw Medical University', 'ror': 'https://ror.org/01qpw1b93', 'country_code': 'PL', 'type': 'education', 'lineage': ['https://openalex.org/I385303915']}], 'countries': ['PL'], 'is_corresponding': False, 'raw_author_name': 'J. Swierkot', 'raw_affiliation_strings': ['Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wrocław, Poland'], 'affiliations': [{'raw_affiliation_string': 'Department of Rheumatology and Internal Medicine, Wroclaw Medical University, Wrocław, Poland', 'institution_ids': ['https://openalex.org/I385303915']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100612794', 'display_name': 'Yong Song', 'orcid': 'https://orcid.org/0000-0003-4979-4131'}, 'institutions': [{'id': 'https://openalex.org/I2948539688', 'display_name': 'AbbVie (United States)', 'ror': 'https://ror.org/02g5p4n58', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I2948539688']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Y. Song', 'raw_affiliation_strings': ['AbbVie Inc., North Chicago, United States of America'], 'affiliations': [{'raw_affiliation_string': 'AbbVie Inc., North Chicago, United States of America', 'institution_ids': ['https://openalex.org/I2948539688']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5100607192', 'display_name': 'Mark C. Genovese', 'orcid': 'https://orcid.org/0000-0001-5294-4503'}, 'institutions': [{'id': 'https://openalex.org/I1743320', 'display_name': 'Palo Alto University', 'ror': 'https://ror.org/04f812k67', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I1743320']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M. C. Genovese', 'raw_affiliation_strings': ['Stanford Univ School of Medicine, Palo Alto, United States of America'], 'affiliations': [{'raw_affiliation_string': 'Stanford Univ School of Medicine, Palo Alto, United States of America', 'institution_ids': ['https://openalex.org/I1743320']}]}], 'institution_assertions': [], 'countries_distinct_count': 6, 'institutions_distinct_count': 9, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.63, 'has_fulltext': False, 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.838113, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 77, 'max': 79}, 'biblio': {'volume': '79', 'issue': 'Suppl 1', 'first_page': '323', 'last_page': '323'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9865, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9865, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9332, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.9109, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9656744}, {'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.8244889}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.7009916}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.6848594}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5871284}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.52161825}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.50582194}, {'id': 'https://openalex.org/C2781059491', 'wikidata': 'https://www.wikidata.org/wiki/Q422232', 'display_name': 'Methotrexate', 'level': 2, 'score': 0.49087697}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.37779105}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.061225772}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2020-eular.1418', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.73, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4283524728', 'https://openalex.org/W3081648646', 'https://openalex.org/W2411121127', 'https://openalex.org/W2396165291', 'https://openalex.org/W2366611537', 'https://openalex.org/W2352867790', 'https://openalex.org/W2326789779', 'https://openalex.org/W2314544353', 'https://openalex.org/W2138243862', 'https://openalex.org/W2106806370'], 'abstract_inverted_index': {'Background:': [0], 'In': [1, 217], 'the': [2, 65, 169, 173, 262, 313, 430, 456, 490, 501], 'SELECT-COMPARE': [3], 'study': [4, 98, 325], 'in': [5, 27, 60, 126, 164, 422, 429], 'rheumatoid': [6], 'arthritis': [7], '(RA)': [8], 'patients': [9, 61, 93, 107, 147, 177, 223, 237, 254, 260], 'with': [10, 62, 91, 379, 450, 455], 'inadequate': [11], 'response': [12], 'to': [13, 35, 42, 57, 76, 112, 115, 119, 154, 206, 228, 242, 249, 257, 322, 412, 476], 'methotrexate': [14], '(MTX),': [15], 'upadacitinib': [16], '(UPA),': [17], 'a': [18, 165], 'Janus': [19], 'Kinase': [20], '(JAK)': [21], '1-selective': [22], 'inhibitor,': [23], 'showed': [24], 'significant': [25], 'improvements': [26, 421], 'treatment': [28, 180], 'of': [29, 52, 70, 315, 324, 329, 352, 392, 470, 489, 500, 507], 'signs': [30], 'and': [31, 38, 50, 189, 221, 232, 251, 296, 301, 327, 335, 361, 372, 387, 407, 424, 454, 597, 612, 688, 699, 756, 778], 'symptoms': [32], 'when': [33], 'compared': [34, 411, 475], 'placebo': [36], '(PBO)': [37], 'adalimumab': [39], '(ADA)': [40], 'up': [41, 56, 205], '48': [43, 102, 175, 266], 'weeks.': [44, 103], '1': [45], 'Objectives:': [46], 'To': [47], 'report': [48], 'safety': [49, 442, 460], 'efficacy': [51], 'UPA': [53, 80, 114, 155, 161, 241, 300, 304, 358, 380, 395, 431, 445, 463], 'vs': [54, 432], 'ADA': [55, 85, 118, 163, 248, 362, 415, 433, 477], '72': [58, 437], 'weeks': [59, 192], 'RA': [63], 'from': [64, 240, 247, 271, 275, 285], 'ongoing': [66], 'long-term': [67], 'extension': [68], '(LTE)': [69], 'SELECT-COMPARE.': [71], 'Methods:': [72], 'Patients': [73, 159], 'were': [74, 108, 149, 152, 203, 224, 238, 245, 255, 294, 354, 376, 426], 'randomized': [75, 214, 225], 'once': [77], 'daily': [78], '(QD)': [79], '15': [81], 'mg,': [82], 'PBO,': [83, 231], 'or': [84, 117, 133, 162, 344], '40': [86], 'mg': [87], 'every': [88, 190], 'other': [89], 'week,': [90], 'all': [92, 145, 252], 'continuing': [94], 'background': [95], 'MTX.': [96, 382], 'The': [97, 291, 349, 441], 'was': [99, 123, 140, 211, 307, 448], 'double-blind': [100], 'for': [101, 299, 366, 444], 'Between': [104], 'Weeks': [105, 131, 385], '14-26,': [106], 'rescued': [109, 151, 274, 284], '(from': [110], 'PBO': [111, 146, 253], 'UPA,': [113, 230, 250], 'ADA,': [116, 233, 243, 302], 'UPA)': [120], 'if': [121, 134], 'there': [122], '&lt;20%': [124], 'improvement': [125], 'tender/swollen': [127], 'joint': [128], 'count': [129], 'at': [130, 142, 156, 185, 226, 264], '14/18/22': [132], 'Clinical': [135], 'Disease': [136], 'Activity': [137], 'Index': [138], '(CDAI)': [139], '&gt;10': [141], 'Week': [143, 157, 174, 186, 265, 436, 481], '26;': [144], 'who': [148], 'not': [150], 'switched': [153, 239, 246, 256, 270], '26.': [158], 'continued': [160, 279, 289], 'blinded': [166], 'manner': [167], 'until': [168], 'last': [170], 'patient': [171, 200, 393], 'completed': [172], 'visit;': [176], 'received': [178], 'open-label': [179], 'thereafter.': [181, 193], 'Study': [182], 'visits': [183], 'occurred': [184], '60,': [187], '72,': [188, 388], '12': [191], 'Treatment-emergent': [194], 'adverse': [195, 341], 'events': [196, 343], '(TEAEs)': [197], 'per': [198], '100': [199], 'years': [201], '(PY)': [202], 'summarized': [204], 'December': [207], '26,': [208], '2018.': [209], 'Efficacy': [210], 'analyzed': [212], 'by': [213, 312], 'group.': [215], 'Results:': [216], 'total,': [218], '651,': [219], '651': [220], '327': [222], 'baseline': [227], 'receive': [229], 'respectively.': [234, 303], 'Subsequently,': [235], '252': [236], '159': [244], 'UPA.': [258], '1403': [259], 'entered': [261], 'LTE': [263], '(UPA:': [267], '1091': [268], '[565': [269], 'PBO;': [272], '66': [273], 'ADA;': [276], '460': [277], 'on': [278, 288], 'UPA];': [280], 'ADA:': [281], '312': [282], '[110': [283], 'UPA;': [286], '202': [287], 'ADA]).': [290], 'cumulative': [292], 'exposures': [293], '1396.7': [295], '515.1': [297], 'PYs': [298], '+': [305, 359, 363, 381, 396, 416, 446, 464, 478], 'MTX': [306, 360, 397, 447, 465, 479], 'generally': [308, 355], 'well-tolerated': [309], 'as': [310], 'assessed': [311], 'frequency': [314], 'AEs,': [316, 319], 'including': [317, 333, 473], 'serious': [318, 334], 'AEs': [320, 328], 'leading': [321], 'discontinuation': [323], 'drug,': [326], 'special': [330], 'interest': [331], '([AESIs]': [332], 'opportunistic': [336], 'infections,': [337], 'malignancy,': [338], 'adjudicated': [339], 'major': [340], 'cardiac': [342], 'venous': [345], 'thromboembolism;': [346], 'Figure': [347, 418], '1).': [348], 'event': [350], 'rates': [351], 'AESIs': [353], 'comparable': [356], 'between': [357], 'MTX,': [364], 'except': [365], 'herpes': [367], 'zoster,': [368], 'lymphopenia,': [369], 'hepatic': [370], 'disorder,': [371], 'CPK': [373], 'elevation,': [374], 'which': [375], 'numerically': [377], 'higher': [378, 468], 'At': [383], 'both': [384], '60': [386], 'significantly': [389, 427, 467], 'greater': [390, 428], 'proportions': [391], 'receiving': [394, 414], 'achieved': [398], 'ACR20/50/70': [399], '(P': [400, 405, 409, 438], '≤.01/.001/.001),': [401], 'low': [402], 'disease': [403], 'activity': [404], '≤.001)': [406, 410], 'remission': [408, 474], 'those': [413], 'MTX;': [417], '2).': [419], 'Similarly,': [420], 'pain': [423], 'function': [425], 'group': [434], 'through': [435, 480], '≤.01).': [439], 'Conclusion:': [440], 'profile': [443], 'consistent': [449], 'that': [451], 'reported': [452], 'previously': [453], 'integrated': [457], 'Phase': [458], '3': [459], 'analysis.': [461], '1,2': [462], 'maintained': [466], 'levels': [469], 'clinical': [471], 'response,': [472], '72.': [482], 'References:': [483], '[1]Fleischmann': [484], 'R,': [485], 'et': [486, 496], 'al.': [487, 497], 'Annals': [488, 499], 'Rheumatic': [491, 502], 'Diseases.': [492], '2019;78:744-745.': [493], '[2]Cohen': [494], 'SB,': [495], 'Thu0167.': [498], 'Diseases': [503], '.': [504], '2019;78:357.': [505], 'Disclosure': [506], 'Interests:': [508], ':': [509], 'Roy': [510], 'Fleischmann': [511], 'Grant/research': [512, 583, 616, 703, 750], 'support': [513, 584, 617, 704, 751], 'from:': [514, 585, 618, 705, 752], 'AbbVie,': [515, 547, 586, 601, 619, 636, 653, 669, 706, 717, 728], 'Akros,': [516], 'Amgen,': [517, 549, 587, 602, 620, 637, 654], 'AstraZeneca,': [518], 'Bristol-Myers': [519, 550, 621, 638, 655, 670], 'Squibb,': [520, 551, 590, 605, 622, 639, 656, 671], 'Boehringer,': [521], 'IngelhCentrexion,': [522], 'Eli': [523, 552, 592, 607, 624, 641, 658, 673, 754, 776], 'Lilly,': [524, 553, 593, 608, 625, 642, 659, 674, 683, 694], 'EMD': [525, 758, 780], 'Serono,': [526, 760, 782], 'Genentech,': [527], 'Gilead,': [528, 554], 'Janssen,': [529, 595, 610, 626, 643, 660, 714, 725, 736], 'Merck,': [530, 627, 644, 661], 'Nektar,': [531], 'Novartis,': [532, 556, 594, 609, 628, 645, 662, 685, 696, 767, 788], 'Pfizer,': [533, 557, 613, 629, 646, 663, 675, 682, 693, 708, 719, 730], 'Regeneron': [534], 'Pharmaceuticals,': [535], 'Inc.,': [536, 566, 570, 576, 580, 742, 746, 765, 769, 786], 'Roche,': [537, 591, 606, 630, 647, 686, 697, 709, 720, 731], 'Samsung,': [538], 'Sandoz,': [539, 707, 718, 729], 'Sanofi': [540, 558, 771, 790], 'Genzyme,': [541, 559, 772], 'Selecta,': [542], 'Taiho,': [543], 'UCB,': [544, 560, 711, 722, 733], 'Consultant': [545, 634, 679, 715, 773], 'of:': [546, 564, 568, 574, 578, 635, 680, 716, 740, 744, 774], 'ACEA,': [548], 'GlaxoSmithKline,': [555], 'In-Ho': [561], 'Song': [562, 738], 'Shareholder': [563, 573, 739], 'AbbVie': [565, 569, 575, 579, 741, 745], 'Employee': [567, 577, 743], 'Jeffrey': [571], 'Enejosa': [572], 'Eduardo': [581], 'Mysler': [582], 'Bristol': [588, 603], 'Myers': [589, 604], 'Sanofi,': [596, 611, 631, 648, 664, 676], 'Pfizer.,': [598], 'Speakers': [599, 651, 667, 690, 726], 'bureau:': [600, 652, 668, 691, 727], 'Louis': [614], 'Bessette': [615], 'Celgene,': [623, 640, 657], 'UCB': [632, 649], 'Pharma,': [633, 650], 'Patrick': [665], 'Durez': [666], 'Celltrion,': [672], 'Andrew': [677], 'Ostor': [678], 'MSD,': [681, 692, 712, 723, 734], 'Abbvie,': [684, 695, 753, 775], 'Gilead': [687, 698, 763, 784], 'BMS,': [689, 700, 710, 721, 732], 'Jerzy': [701], 'Swierkot': [702], 'Accord,': [713, 724, 735], 'Yanna': [737], 'Mark': [747], 'C.': [748], 'Genovese': [749], 'Lilly': [755, 777], 'Company,': [757, 779], 'Merck': [759, 781], 'Galapagos,': [761], 'Genentech/Roche,': [762, 783], 'Sciences,': [764, 785], 'GSK,': [766, 787], 'Pfizer': [768], 'RPharm,': [770, 789], 'Genzyme': [791]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3034508941', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}], 'updated_date': '2024-12-12T16:46:38.991710', 'created_date': '2020-06-19'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
